ZHEN-AO Takes a Lead in the "Healthy China" Programme

          Nuclein, now known as nucleic acid, was first found in cell nucleus by the Swiss biologist Friedrich Miescher in 1868. Later, in 1953, British biophysicist Francis Crick and American biochemist James Watson discovered the double helix model of DNA structure and pushed the nuclide research to a new stage, which ushered a new era of life science.

          It was ZHEN-AO that first introduced nucleic acid to civilian use in China. ZHEN-AO, established in 1996 and based in ZHEN-AO Bio Valley, is located in Dalian Advanced Equipment Manufacturing Zone with an area of 38,000 square meters and a total investment over 2.2 billion yuan.

          After twenty years of development, ZHEN-AO has become one of the leading enterprises in both Dalian's biotech industry and also China's health industry. Also, ZHEN-AO has established long-term cooperation relationship with a dozen research institutes and over one hundred scientists at home and abroad.

          In the years to come, ZHEN-AO will focus on the health industry and stick to the strategic goal of developing itself into an enterprise with profit, competitiveness and sustainability. ZHEN-AO will also put forward the blueprint of health service system by improving both environment and management for health service industry. With its core advantage and competitiveness, ZHEN-AO will keep moving forward and develop itself into a leading Chinese biotech company with international competitiveness.